These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7986892)

  • 21. Pharmacokinetics of cyproterone acetate and its main metabolite 15 beta-hydroxy-cyproterone acetate in young healthy women.
    Huber J; Zeillinger R; Schmidt J; Täuber U; Kuhnz W; Spona J
    Int J Clin Pharmacol Ther Toxicol; 1988 Nov; 26(11):555-61. PubMed ID: 2977383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sadistic homosexual pedophilia treatment with cyproterone acetate.
    Cooper AJ; Baxter D; Wong W; Losztyn S
    Can J Psychiatry; 1987 Nov; 32(8):738-40. PubMed ID: 2961433
    [No Abstract]   [Full Text] [Related]  

  • 23. [Serum hormones before and during therapy with cyproterone acetate and spironolactone in patients with androgenization].
    Grunwald K; Rabe T; Schlereth G; Runnebaum B
    Geburtshilfe Frauenheilkd; 1994 Nov; 54(11):634-45. PubMed ID: 8719011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Androcur (cyproterone acetate in sex offenses--follow-up of psychiatric admissions].
    Ahrens R
    Schweiz Arch Neurol Psychiatr (1985); 1991; 142(2):171-88. PubMed ID: 1710391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relative effectiveness of alternative androgen withdrawal therapies in initiating regression of rat prostate.
    Rennie PS; Bruchovsky N; Goldenberg SL; Lawson D; Fletcher T; Foekens JA
    J Urol; 1988 Jun; 139(6):1337-42. PubMed ID: 2967378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of testosterone suppression and recovery on sexual function in men with prostate cancer: observations from a prospective study in men undergoing intermittent androgen suppression.
    Ng E; Woo HH; Turner S; Leong E; Jackson M; Spry N
    J Urol; 2012 Jun; 187(6):2162-6. PubMed ID: 22503022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and hormonal effects of gonadotropin-releasing hormone agonist plus an oral contraceptive in severely hirsute patients with polycystic ovary disease.
    Ciotta L; Cianci A; Giuffrida G; Marletta E; Aglianò A; Palumbo G
    Fertil Steril; 1996 Jan; 65(1):61-7. PubMed ID: 8557156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anti-androgen treatment of hirsutism with cyproterone acetate].
    Kása M; Egyedi K; Raffai S; Török L
    Z Hautkr; 1990 Dec; 65(12):1112-4. PubMed ID: 2150902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gonadotrophin-releasing hormone agonist therapy for hirsutism is as effective as high dose cyproterone acetate but results in a longer remission.
    Carmina E; Lobo RA
    Hum Reprod; 1997 Apr; 12(4):663-6. PubMed ID: 9159420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolactinoma induced by estrogen and cyproterone acetate in a male-to-female transsexual.
    García-Malpartida K; Martín-Gorgojo A; Rocha M; Gómez-Balaguer M; Hernández-Mijares A
    Fertil Steril; 2010 Aug; 94(3):1097.e13-5. PubMed ID: 20227072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Drug modulation of libido and sexual activity. Behavior effect of GnRH analog in man].
    Thibaut F; Cordier B; Kuhn JM
    Ann Endocrinol (Paris); 1994; 55(6):229-33. PubMed ID: 7864578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hepatocellular carcinoma in a healthy liver possibly due to long-term use of cyproterone acetate].
    Manfredi S; Lenfant L; Gresset AC; Bonnotte B; Lorcerie B; Chauffert B
    Presse Med; 2000 Nov; 29(36):1983. PubMed ID: 11149080
    [No Abstract]   [Full Text] [Related]  

  • 33. Osteoporosis associated with the treatment of paraphilias: a clinical review of seven case reports.
    Grasswick LJ; Bradford JM
    J Forensic Sci; 2003 Jul; 48(4):849-55. PubMed ID: 12877306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medroxyprogesterone acetate antiandrogen treatment of hypersexuality in a pedophiliac sex offender.
    Cordoba OA; Chapel JL
    Am J Psychiatry; 1983 Aug; 140(8):1036-9. PubMed ID: 6223535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Long-term side-effects following cyproterone acetate containing therapy in gynecology].
    Regidor PA; Speer K; Regidor M; Schindler EM
    Zentralbl Gynakol; 2000; 122(5):268-73. PubMed ID: 10857213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of meningioma among users of high doses of cyproterone acetate as compared with the general population: evidence from a population-based cohort study.
    Gil M; Oliva B; Timoner J; Maciá MA; Bryant V; de Abajo FJ
    Br J Clin Pharmacol; 2011 Dec; 72(6):965-8. PubMed ID: 21627676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leuprolide acetate given by a subcutaneous extended-release injection: less of a pain?
    Cox MC; Scripture CD; Figg WD
    Expert Rev Anticancer Ther; 2005 Aug; 5(4):605-11. PubMed ID: 16111462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination treatment versus LHRH alone in advanced prostatic cancer.
    Ferrari P; Castagnetti G; Ferrari G; Baisi B; Dotti A
    Urol Int; 1996; 56 Suppl 1():13-7. PubMed ID: 8776812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LHRH analogues and PCO disease: validity of the use of enantone depot in the treatment of the disease.
    Vitale F; Ruggieri P
    Acta Eur Fertil; 1992; 23(6):293-5. PubMed ID: 1343754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiation of homicidal child molesters, nonhomicidal child molesters, and nonoffenders by phallometry.
    Firestone P; Bradford JM; Greenberg DM; Nunes KL
    Am J Psychiatry; 2000 Nov; 157(11):1847-50. PubMed ID: 11058484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.